Effect of botulinum toxin injection on nocturnal bruxism: A randomized controlled trial

American Journal of Physical Medicine and Rehabilitation

Volumn 89, Issue 1, 2010, Pages 16-23

  Lee, Seung Jin ^a   McCall, Willard D ^b   Kim, Young Ku ^a   Chung, Sung Chang ^a   Chung, Jin Woo ^a  

^a Seoul National University   (South Korea)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Electromyography; Masseter Muscle; Randomized Controlled Trial; Temporalis Muscle

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; ARTICLE; BRUXISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL;

ADULT; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; NEUROMUSCULAR AGENTS; PATIENT SATISFACTION; SLEEP BRUXISM; YOUNG ADULT;

EID: 73949089268     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e3181bc0c78     Document Type: Article

References (30)

1. Lavigne GJ, Kato T, Kolta A, et al: Neurobiological mechanisms involved in sleep bruxism. Crit Rev Oral Biol Med 2003;14:30-46
2. Bader G, Lavigne G: Sleep bruxism: An overview of an oromandibular sleep movement disorder. Sleep Med Rev 2000;4:27-43
3. Egermark-Eriksson I, Carlsson GE, Ingervall B: Prevalence of mandibular dysfunction and orofacial parafunction in 7-, 11-, and 15-year-old Swedish children. Eur J Orthod 1981;3:163-172
4. American Academy of Sleep Medicine. International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual. Chicago, IL, American Academy of Sleep Medicine, 2001
5. Lavigne GJ, Montplaisir JY: Restless legs syndrome and sleep bruxism: Prevalence and association among Canadians. Sleep 1994;17:739-743
6. Pierce CJ, Chrisman K, Bennett ME, et al: Stress, anticipatory stress, and psychologic measures related to sleep bruxism. J Orofac Pain 1995;9:51-56
7. Rugh JD, Barghi N, Drago CJ: Experimental occlusal discrepancies and nocturnal bruxism. J Prosthet Dent 1984;51:548-553
8. Lobbezoo F, Naeije M: Bruxism is mainly regulated centrally, not peripherally. J Oral Rehabil 2001;28: 1085-1091
9. Haketa T, Baba K, Akishige S, et al: Utility and validity of a new EMG-based bruxism detection system. Int J Prosthodont 2003;16:422-428
10. Ikeda T, Nishigawa K, Kondo K, et al: Criteria for the detection of sleep-associated bruxism in humans. J Orofac Pain 1996;10:270-282
11. Takeuchi H, Ikeda T, Clark GT: A piezoelectric filmbased intrasplint detection method for bruxism. J Prosthet Dent 2001;86:195-202
12. Okeson JP: The effects of hard and soft occlusal splints on nocturnal bruxism. J Am Dent Assoc 1987; 114:788-791
13. Saletu A, Parapatics S, Saletu B, et al: On the pharmacotherapy of sleep bruxism: Placebo-controlled polysomnographic and psychometric studies with clonazepam. Neuropsychobiology 2005;51:214-225
14. Van Zandijcke M, Marchau MM: Treatment of bruxism with botulinum toxin injections. J Neurol Neurosurg Psychiatry 1990;53:530
15. Ivanhoe CB, Lai JM, Francisco GE: Bruxism after brain injury: Successful treatment with botulinum toxin-A. Arch Phys Med Rehabil 1997;78:1272-1273
16. Watts MW, Tan EK, Jankovic J: Bruxism and cranialcervical dystonia: Is there a relationship? Cranio 1999;17:196-201
17. Tan EK, Jankovic J: Treating severe bruxism with botulinum toxin. J Am Dent Assoc 2000;131:211-216
18. Pidcock FS, Wise JM, Christensen JR: Treatment of severe post-traumatic bruxism with botulinum toxin-A: Case report. J Oral Maxillofac Surg 2002; 60:115-117
19. See SJ, Tan EK: Severe amphetamine-induced bruxism: Treatment with botulinum toxin. Acta Neurol Scand 2003;107:161-163
20. Nash MC, Ferrell RB, Lombardo MA, et al: Treatment of bruxism in Huntington's disease with botulinum toxin. J Neuropsychiatry Clin Neurosci 2004;16:381-382
21. Monroy PG, da Fonseca MA: The use of botulinum toxin-A in the treatment of severe bruxism in a patient with autism: A case report. Spec Care Dentist 2006;26:37-39
22. Guarda-Nardini L, Manfredini D, Salamone M, et al: Efficacy of botulinum toxin in treating myofascial pain in bruxers: A controlled placebo pilot study. Cranio 2008;26:126-135
23. Brueggemann N, Doegnitz L, Harms L, et al: Skin reactions after intramuscular injection of botulinum toxin A: A rare side effect. J Neurol Neurosurg Psychiatry 2008;79:231-232
24. Li M, Goldberger BA, Hopkins C: Fatal case of Botoxrelated anaphylaxis? J Forensic Sci 2005;50:169-172
25. Guyuron B, Rose K, Kriegler JS, et al: Hourglass deformity after botulinum toxin type A injection. Headache 2004;44:262-264
26. Jankovic J, Brin MF: Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-1194
27. Park MY, Ahn KY, Jung DS: Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg 2003;29:477-483
28. Borodic G: Botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications. Facial Plast Surg Clin North Am 2007;15:11-16
29. Mandel L, Tharakan M: Treatment of unilateral masseteric hypertrophy with botulinum toxin: Case report. J Oral Maxillofac Surg 1999;57:1017-1019
30. Koyano K, Tsukiyama Y, Ichiki R, et al: Assessment of bruxism in the clinic. J Oral Rehabil 2008;35:495-508